The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry entitled ``Controlled Correspondence Related to Generic Drug Development''. The guidance document provides information regarding the process by which human generic drug manufacturers and related industry can submit correspondence to FDA requesting information on generic drug development. This guidance also describes FDA's process for providing communications related to such correspondence.
Document
Controlled Correspondence Related to Generic Drug Development; Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance for industry entitled ``Controlled Correspondence Related to Generic Drug Developme...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
80 FR 58491
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Controlled Correspondence Related to Generic Drug Development; Guidance for Industry; Availability,” thefederalregister.org (September 29, 2015), https://thefederalregister.org/documents/2015-24621/controlled-correspondence-related-to-generic-drug-development-guidance-for-industry-availability.